Physitrack (PTRK.ST) Stock Price

Physitrack Price

OMX·CLOSED
1.12
​
Market closed

Revenue has compounded at 78.4% per year over the past 11 years to 13.77 M EUR. Earnings per share have grown at 47.6% per year over the last 3 years. Physitrack's net margin stands at -50.3%, down from -10.4% several years earlier.

Physitrack stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Physitrack business model & stock analysis

Physitrack Plc engages in the provision of digital healthcare services for the business-to-business physiotherapy market. The firm is focused on providing technology to care providers and providing virtual-first wellness solutions to corporates. The company operates through two business lines: Lifecare Technology and Virtual Wellness. Lifecare technology business line is a full-service offering built around Company’s software as a service (SaaS) solution. The company offers physiotherapy and musculoskeletal care, enabling practitioners to digitally deliver clinical home exercises, education prescription, outcomes tracking, triaging and Telehealth. Its Virtual Wellness and care provision powered by the Champion Health technology platform and wellness professionals is based in the United Kingdom, Germany, and the Nordics. The firm's software features include exercise prescription and education, outcomes analysis, patient onboarding and triage, telehealth and messaging, collaboration and security and privacy.

Frequently asked questions about Physitrack

7 analysts currently rate the Physitrack stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Physitrack to generate revenue of 13.90 M EUR and earnings per share of 0.01 EUR.

The Physitrack share (PTRK.ST) is listed on 3 stock exchanges, including: Frankfurt (6UC.F), Stockholm (PTRK.ST).

The expected revenue of Physitrack is 13.90 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Physitrack is 145,440.13 EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Physitrack is currently 124.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Physitrack stock.

The price-to-sales ratio (P/S) of Physitrack is currently 1.30. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Physitrack stock.

The Eulerpool Quality Score for Physitrack is 3/10.

The ISIN of Physitrack is GB00BK80TJ35. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Physitrack is PTRK.ST. The ticker symbol is used to trade Physitrack shares on the stock exchange.

Fair ValueTerminal
0.96 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
163,961.71 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
EUR
Initial public offering
Jun 18, 2021
ISIN
GB00BK80TJ35
Cusip
G7097G114
Market capitalization
18.13 M EURMicro Cap
52-Week Range
PEG
-0.03
P/E ratio
P/Ee 2026
124.68
P/Ee 2027
124.68
P/Ee 2027
10.89
P/Ee 2028
10.89
P/S
P/Se
1.30
EV/EBIT
41.32
P/B Ratio
1.82
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-49.88 %
Last updated Oct 21, 2026, 6:07 AM

Physitrack Peer Group

Physitrack Ticker

FRANKFURT · 6UC.FSTOCKHOLM · PTRK.STSTOCKHOLM · PTRK.ST

Physitrack FIGI

PTRK:SF · BBG0115V1PB3PTRKSEK:XH · BBG011DVPT39PTRKSEK:XF · BBG011DVPT57PTRKSEK:XE · BBG011DVPT75PTRKSEK:XL · BBG011DVPT93PTRKSEK:XG · BBG011DVPTB0PTRKSEK:XO · BBG011DVPTC9PTRKSEK:XA · BBG011DVPTH4PTRKSEK:XT · BBG011DVPTK0PTRKSEK:XW · BBG011DVPTL9PTRKSEK:XU · BBG011DVPTM8PTRKSEK:XV · BBG011DVPTP5

All fundamentals and in-depth analysis of Physitrack

Our stock analysis for Physitrack stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Physitrack. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.